(1888 PressRelease) The device is programmed to recognize a target on a cell surface; its drug payload secured within anchor strands of DNA. The nanorobots track down specific cell types, thanks to their molecular latches. Those two strands of twisted DNA fragments, can be designed to react to a specific chemical marker, or ligand, on the surface of a particular cell type, such as those in a cancerous tumor.
No comments:
Post a Comment